[NEU] QoQ Quarter Result on 30-Sep-2013 [#Q3]

Stock
[NEU] Neuren Pharmaceuticals Limited
Announcement Date
29-Sep-2013
Financial Year
2013
Quarter
30-Sep-2013 [#Q3]
Profit Trend
QoQ- 7.74%
YoY- -121.92%
Quarter Report
NEU's Result
NEU's Financial Summary
View:
Show?
Quarter Result
31/12/14 30/06/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Revenue 1,506 1,425 2,047 0 2,747 0 0 -
PBT -3,645 -4,671 -7,381 -2,834 -3,089 -2,834 -2,834 13.40%
Tax -4 -15 -5 -9 -9 -9 -9 -33.33%
NP -3,641 -4,656 -7,374 -2,825 -3,062 -2,825 -2,825 13.52%
Tax Rate - - - - - - - -
Total Cost 5,147 6,081 9,421 2,825 5,809 2,825 2,825 34.97%
Ratio Analysis
31/12/14 30/06/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
NP Margin -241.77 -326.74 -360.23 0.00 -111.47 0.00 0.00 -
Per Share
31/12/14 30/06/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
EPS -0.05 -0.06 -0.11 -0.04 -0.05 -0.04 -0.04 11.80%
EPS Diluted -0.05 -0.06 -0.11 -0.04 -0.05 -0.04 -0.04 11.80%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.